回盛生物：公司持续深化“原料-制剂一体化”战略

Core Insights - The company is adapting to a changing market environment and competitive landscape by deepening its "raw material-formulation integration" strategy, which is expected to stabilize raw material supply and control costs, thereby enhancing product competitiveness [2] Group 1 - The company is facing a continuously evolving market environment and competitive dynamics [2] - The "raw material-formulation integration" strategy is aimed at ensuring stable raw material supply and cost control [2] - This strategy is expected to raise competitive barriers and enhance product market competitiveness [2]